Cargando…
Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization
OBJECTIVES: To measure the per-event health plan costs for acute and follow-up treatment not directed by a clinical study protocol in a group of commercially insured patients in 2 managed care organizations following an incident hospitalization that included a diagnosis for a venous thromboembolism...
Autores principales: | Bullano, Michael F., Willey, Vincent, Hauch, Ole, Wygant, Gail, Spyropoulos, Alex C., Hoffman, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437668/ https://www.ncbi.nlm.nih.gov/pubmed/16194130 http://dx.doi.org/10.18553/jmcp.2005.11.8.663 |
Ejemplares similares
-
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020) -
Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
por: Ferrazzini, Elisa, et al.
Publicado: (2022) -
Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023) -
Venous thromboembolism events among RA patients
por: Mansour, Ribhi, et al.
Publicado: (2019) -
The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events
por: Sharman Moser, Sarah, et al.
Publicado: (2021)